prednisolone has been researched along with Craniopharyngioma, Adamantinous in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adipsic diabetes insipidus is an infrequent disease which may be associated with craniopharyngioma." | 1.51 | Adipsic diabetes insipidus secondary to craniopharyngioma resection. ( Flórez Romero, A; Millán, HA; Naranjo, JA; Pérez, MA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez, MA | 1 |
| Millán, HA | 1 |
| Naranjo, JA | 1 |
| Flórez Romero, A | 1 |
1 other study available for prednisolone and Craniopharyngioma, Adamantinous
| Article | Year |
|---|---|
Adipsic diabetes insipidus secondary to craniopharyngioma resection.
Topics: Antidiuretic Agents; Craniopharyngioma; Deamino Arginine Vasopressin; Diabetes Insipidus; Female; Hu | 2019 |